Erratum: A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation (Nature Communications (2014) 5 (3065) (DOI:10.1038/ncomms4065));A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation

Nature Communications

Volumn 5, Issue , 2014, Pages

  Duivenvoorden, Raphaël ^a,b   Tang, Jun ^a   Cormode, David P ^a,h   Mieszawska, Aneta J ^a   Izquierdo Garcia, David ^a   Ozcan, Canturk ^a   Otten, Maarten J ^a   Zaidi, Neeha ^a   Lobatto, Mark E ^a,b   Van Rijs, Sarian M ^a   Priem, Bram ^a   Kuan, Emma L ^a   Martel, Catherine ^c   Hewing, Bernd ^d,e   Sager, Hendrik ^f   Nahrendorf, Matthias ^f   Randolph, Gwendalyn J ^c   Stroes, Erik S G ^b   Fuster, Valentin ^a,g   Fisher, Edward A ^e   Fayad, Zahi A ^a   Mulder, Willem J M ^a,b   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c WASHINGTON UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NANOPARTICLE;

ANIMAL; DEFICIENCY; DISEASE MODEL; DOSE RESPONSE; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; KNOCKOUT MOUSE; MALE; MOUSE; PLAQUE, ATHEROSCLEROTIC; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ANIMALS; APOLIPOPROTEINS E; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPOPROTEINS, HDL; MALE; MICE; MICE, KNOCKOUT; NANOPARTICLES; PLAQUE, ATHEROSCLEROTIC; TREATMENT OUTCOME;

EID: 84892865604     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4531     Document Type: Erratum

References (36)

1. Grundy, S. M. et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227-239 (2004 (Pubitemid 38924592)
2. Libby, P. The forgotten majority: Unfinished business in cardiovascular risk reduction. J. Am. Coll. Cardiol. 46, 1225-1228 (2005 (Pubitemid 41615541)
3. Milonas, C. et al. Effect of angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction. Am. J. Cardiol. 105, 1229-1234 (2010
4. Dutta, P. et al. Myocardial infarction accelerates atherosclerosis. Nature 487, 325-329 (2012
5. Libby, P., Ridker, P. M. & Hansson, G. K. Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317-325 (2011
6. van der Wal, A. C., Becker, A. E., van der Loos, C. M. & Das, P. K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89, 36-44 (1994 (Pubitemid 24026469)
7. Weber, C. & Noels, H. Atherosclerosis: Current pathogenesis and therapeutic options. Nat. Med. 17, 1410-1422 (2011
8. Goldstein, J. L. & Brown, M. S. Regulation of the mevalonate pathway. Nature 343, 425-430 (1990
9. Kwak, B., Mulhaupt, F., Myit, S. & Mach, F. Statins as a newly recognized type of immunomodulator. Nat. Med. 6, 1399-1402 (2000 (Pubitemid 32001026)
10. Weitz-Schmidt, G. et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7, 687-692 (2001 (Pubitemid 32588024)
11. Pahan, K., Sheikh, F. G., Namboodiri, A. M. & Singh, I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J. Clin. Invest. 100, 2671-2679 (1997 (Pubitemid 28007534)
12. Sparrow, C. P. et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler. Thromb. Vasc. Biol. 21, 115-121 (2001 (Pubitemid 32061935)
13. Armitage, J. The safety of statins in clinical practice. Lancet. 370, 1781-1790 (2007 (Pubitemid 350137473)
14. Bellosta, S., Paoletti, R. & Corsini, A. Safety of statins: Focus on clinical pharmacokinetics and drug interactions. Circulation 109, III50-III57 (2004 (Pubitemid 38786444)
15. Bell, F. P. Lipid exchange and transfer between biological lipid-protein structures. Proq. Lipid Res. 17, 207-243 (1978
16. Skajaa, T et al. Quantum dot and Cy5.5 labelled nanoparticles to investigate lipoprotein biointeractions via Förster resonance energy transfer. Nano Lett. 10, 5131-5138 (2010
17. Skajaa, T. et al. The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis. Biomaterials 32, 206-213 (2011
18. Osada, J., Joven, J. & Maeda, N. The value of apolipoprotein E knockout mice for studying the effects of dietary fat and cholesterol on atherogenesis. Curr. Opin. Lipidol. 11, 25-29 (2000 (Pubitemid 30148194)
19. Quarfordt, S. H. et al. In vivo cholesterol kinetics in apolipoprotein E-deficient and control mice. J. Lipid Res. 36, 1227-1235 (1995
20. Vyas, K. P., Kari, P. H., Prakash, S. R. & Duggan, D. E. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin. Drug Metab. Dispos. 18, 218-222
21. Rader, D. Molecular regulation of HDL metabolism and function: Implications for novel therapies. J. Clin. Invest. 116, 3090-3100 (2006 (Pubitemid 44878620)
22. Tall, A. R., Yvan-Charvet, L., Terasaka, N., Pagler, T. & Wang, N. HDL, ABC transporters, and cholesterol efflux: Implications for the treatment of atherosclerosis. Cell Metab. 7, 365-375 (2008 (Pubitemid 351598023)
23. Shah, P. K. et al. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. Circulation 97, 780-785 (1998 (Pubitemid 28135341)
24. Shah, P. K. et al. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation 103, 3047-3050 (2001 (Pubitemid 32587849)
25. Nissen, S. E. et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial. JAMA 290, 2292-2300 (2003 (Pubitemid 37430562)
26. Tardif, J. C. et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: A randomized controlled trial. JAMA 297, 1675-1682 (2007
27. Vaisar, T. et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117, 746-756 (2007 (Pubitemid 46348533)
28. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. & Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433 (2011
29. Liao, J. K. Isoprenoids as mediators of the biological effects of statins. J. Clin. Invest. 110, 285-288 (2002 (Pubitemid 34847957)
30. Jain, M. K. & Ridker, P. M. Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms. Nat. Rev. Drug Discov. 4, 977-987 (2005
31. Lobatto, M. E., Fuster, V., Fayad, Z. A. & Mulder, W. J. M. Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat. Rev. Drug Discov. 10, 835-852 (2011
32. Jonas, A. N. A. Apolipoproteins. Methods 128, 553-582 (1986
33. Forte, T. Electron microscopy of negatively stained lipoproteins. Methods Enzymol. 128, 442-457 (1986 (Pubitemid 16100910)
34. Carlucci, G., Mazzeo, P., Biordi, L. & Bologna, M. Simultaneous determination of simvastatin and its hydroxy acid form in human plasma by highperformance liquid chromatography with UV detection. J. Pharm. Biomed. Anal. 10, 693-697 (1992 (Pubitemid 23009573)
35. Trogan, E. et al. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc. Natl Acad. Sci. USA 99, 2234-2239 (2002 (Pubitemid 34169044)
36. Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509 (1957